Skip to main content
Interparfums logo

Interparfums — Investor Relations & Filings

Ticker · ITP ISIN · FR0004024222 LEI · 969500SARWF33OPQED48 PA Manufacturing
Open in API
Filings indexed 678 across all filing types
Latest filing 2025-05-05 Declaration of Voting R…
Country FR France
Listing PA ITP

About Interparfums

https://www.interparfums.fr/en/index-2/

Interparfums specializes in the creation, manufacturing, and distribution of prestige fragrances and related cosmetic products. Operating primarily as an exclusive worldwide licensee, the company develops and markets perfumes for a portfolio of renowned luxury and fashion brands. It manages the entire product lifecycle, from concept and scent development to packaging, marketing, and global distribution. In addition to its core licensing business, the company also develops its own proprietary fragrance brands.

Recent filings

Filing Released Lang Actions
Déclaration mensuelle du nombre total de droits de vote et du nombre d'actions composant le capital
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled "Déclaration mensuelle du nombre total de droits de vote et du nombre d'actions composant le capital" (Monthly declaration of the total number of voting rights and the number of shares comprising the capital). It explicitly references French regulatory articles (Code de Commerce and AMF General Regulation) and provides a snapshot of the total shares and voting rights as of April 30, 2025. This type of periodic disclosure regarding the capital structure and voting rights is a specific regulatory filing, but it does not map perfectly to the provided definitions for standard US filings (like 10-K, ER, etc.). However, it is a formal regulatory announcement concerning share capital and voting rights. Given the options, it is closest to a general regulatory filing or a specific announcement related to capital structure. Since it is a formal declaration of the total number of voting rights and shares, it is a specific type of regulatory disclosure. Among the choices, 'RNS' (Regulatory Filings - general/miscellaneous) is the most appropriate fallback for a specific, non-US-centric regulatory disclosure that doesn't fit other categories like DIV, SHA, or DVA (which is specifically for *results* of votes, not the current capital structure count). However, since it directly relates to the total number of shares and voting rights, it is a fundamental capital structure update. Given the options, and recognizing this is a mandatory periodic disclosure, 'RNS' serves as the best fit for a non-standard regulatory report, although 'SHA' (Share Issue/Capital Change) is related, this is a reporting of the *current state* rather than an announcement of a *change* in issue. I will classify it as RNS as the best general regulatory filing category available.
2025-05-05 French
2025 first quarter sales: €235.5m (+10.7%). Solid growth
Earnings Release Classification · 99% confidence The document provides a summary of financial performance for the '2025 first quarter' including sales figures, brand breakdowns, regional performance, and commentary from the CEO. It is a concise announcement of period results, not the comprehensive report itself (like a 10-K or IR). The content aligns perfectly with the definition of an Earnings Release (ER), which focuses on key highlights immediately following the period end. The document is dated April 24, 2025, which is typical for a Q1 earnings announcement. It is not a full transcript (CT), a detailed management discussion (MDA), or a formal regulatory filing announcing the release of a report (RPA). Q1 2025
2025-04-24 English
Chiffre d'affaires 1er trimestre 2025 : 235,5 M€ (+10,7 %). Une croissance solide
Earnings Release Classification · 99% confidence The document is a press release announcing the company's revenue ('Chiffre d'affaires') for the first quarter of 2025 ('1er trimestre 2025'). It provides key financial highlights, performance breakdowns by brand and geography, and a quote from the CEO, concluding with the date of the announcement (April 24, 2025) and contact information. This structure is characteristic of an Earnings Release (ER), which provides initial, high-level results for a reporting period shorter than a year, distinct from the comprehensive Interim Report (IR) or the full Annual Report (10-K). Since it focuses on the initial release of quarterly results, 'ER' is the most appropriate classification. Q1 2025
2025-04-24 French
Description of the share repurchase program authorized by the Combined General Meeting of the shareholders of April 17, 2025
Transaction in Own Shares Classification · 100% confidence The document explicitly describes the 'Description of the share repurchase program authorized by the Combined General Meeting of the shareholders of April 17, 2025'. It details the purposes, maximum number of shares, price, and duration of the program, which is a core activity related to a company buying back its own shares. This directly aligns with the definition for 'Transaction in Own Shares' (POS). Although it references the AGM authorization, the content is the detailed plan for the repurchase, not the AGM materials (AGM-R) or the voting results (DVA).
2025-04-22 English
Descriptif du programme de rachat d'actions autorisé par l'Assemblée générale mixte des actionnaires du 17 avril 2025
Transaction in Own Shares Classification · 100% confidence The document is titled "Descriptif du programme de rachat d'actions autorisé par l'Assemblée générale mixte des actionnaires du 17 avril 2025" (Description of the share repurchase program authorized by the Combined General Meeting of Shareholders of April 17, 2025). It details the objectives, maximum number of shares, purchase price, and duration of a share repurchase program, which is explicitly authorized by a shareholder meeting. This content directly relates to the company buying back its own shares. The most specific category for reporting on the company buying back or selling its own shares is 'Transaction in Own Shares' (POS). While it mentions the AGM authorization, the core subject is the repurchase plan itself, not the AGM results (DVA) or the general AGM materials (AGM-R).
2025-04-22 French
Déclaration mensuelle du nombre total de droits de vote et du nombre d'actions composant le capital
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled "Déclaration mensuelle du nombre total de droits de vote et du nombre d'actions composant le capital" (Monthly declaration of the total number of voting rights and the number of shares comprising the capital) and is dated as of March 31, 2025. It explicitly references French commercial code (L.233-8 du Code de Commerce) and AMF regulations (Article 222-12-5 du Règlement général de l'Autorité des Marchés Financiers). This content directly relates to reporting changes in the total number of voting rights and shares outstanding, which is a specific regulatory disclosure in France. This aligns best with the 'Declaration of Voting Results & Voting Rights Announcements' (DVA), as it is a formal declaration regarding voting rights, even though it is a monthly update rather than post-meeting results. It is not a general earnings release (ER), a full annual report (10-K), or a director's dealing report (DIRS). Given the specific nature of reporting voting rights, DVA is the most precise fit.
2025-04-04 French

Browse filings by year

19 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.